Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate in Quadruple Therapy for H. Pylori
NCT06591494Phase 3Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of sodium bicarbonate in Helicobacter pylori infection (3 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Helicobacter pylori eradication rate. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06591494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06591494.